A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06230224 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06230224
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2028-05-29
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.